FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis

Frontiers in Genetics - Switzerland
doi 10.3389/fgene.2020.00113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Prognostic Genes of Triple‑negative Breast Cancer Identified by Weighted Gene Co‑expression Network Analysis

Oncology Letters
Cancer ResearchOncology
2019English

Weighted Gene Co-Expression Network Analysis Identified Cancer Cell Proliferation as a Common Phenomenon During Perineural Invasion

OncoTargets and Therapy
OncologyPharmacology
2019English

Systemic Chemotherapy With FOLFOX in Metastatic Grade 1/2 Neuroendocrine Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Co-Expression Network Analysis Identified CDH11 in Association With Progression and Prognosis in Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Potential Responders to FOLFOX Therapy for Colorectal Cancer by Random Forests Analysis

British Journal of Cancer
Cancer ResearchOncology
2011English

Overexpression of COL3A1 Confers a Poor Prognosis in Human Bladder Cancer Identified by Co-Expression Analysis

Oncotarget
Oncology
2017English

A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2012English

Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly

British Journal of Cancer
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy